Beximco Pharmaceuticals (DHA:BXPHARMA) Ending Cash Position : BDT1,160 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Ending Cash Position?

Beximco Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2024 was BDT1,160 Mil.

Beximco Pharmaceuticals's quarterly Ending Cash Position declined from Jun. 2023 (BDT1,136 Mil) to Dec. 2023 (BDT0 Mil) but then increased from Dec. 2023 (BDT0 Mil) to Mar. 2024 (BDT1,160 Mil).

Beximco Pharmaceuticals's annual Ending Cash Position increased from Jun. 2021 (BDT675 Mil) to Jun. 2022 (BDT1,169 Mil) but then declined from Jun. 2022 (BDT1,169 Mil) to Jun. 2023 (BDT1,136 Mil).

Beximco Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Beximco Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Ending Cash Position Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Ending Cash Position

Get a 7-Day Free Trial

610.49

635.02

675.47

1,168.67

1,135.69

Beximco Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															1,246.53	983.81	1,135.69	-	1,160.42

Beximco Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Beximco Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1168.674	+	-32.988
	=	1,136

Beximco Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1095.813	+	64.611
	=	1,160

Beximco Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Ending Cash Position

Traded in Other Exchanges

BXP:UK R2WA:Germany

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines